Currently, navigating the legality of psychedelic assisted therapy (PAT) can feel akin to traversing a diverse terrain – while the federal stance on psychedelics remains restrictive, individual states are forging their own paths forward. 

Oregon has emerged as a pioneer, becoming the first state to officially sanction psilocybin therapy through the passage of Measure 109 in 2020. This landmark legislation permits licensed guides to assist individuals in exploring the therapeutic potential of psilocybin. Additionally, several states including California, Connecticut, New Mexico, and Vermont have adopted a more relaxed stance on psilocybin possession, signaling a shift in attitudes toward these substances. Maryland is also considering similar measures, while Colorado’s Proposition 122 has decriminalized psilocybin for personal use, potentially paving the way for future therapeutic applications. 

Moreover, there is growing excitement within the scientific community surrounding the therapeutic efficacy of substances like MDMA, psilocybin, and ketamine. The FDA’s approval of ketamine for the treatment of depression and anxiety represents a significant advancement in the field of mental health care. 

However, it is essential to acknowledge the obstacles that remain. Rescheduling psychedelics at the federal level and ensuring equitable access to these therapies are critical challenges that must be addressed. Nonetheless, the momentum behind PAT in the USA is palpable, offering hope for individuals seeking alternative approaches to mental health and personal growth. 

At JourneyŌM, we operate within the bounds of the law, providing a legal and ethical concierge service that connects seekers with experienced guides. Our mission is to facilitate safe and supportive journeys, adhering to all regulatory guidelines and prioritizing the well-being of our clients. 

Join us as we navigate the evolving landscape of PAT, and discover the transformative potential that lies ahead. Here are more resources you may find useful:

• • • An interactive map of psychedelic drug policy reform in the United States, psychedelicalpha.com
    • Psychedelic Drug Development Tracker, psychedelicalpha.com
    • The JourneyŌM resources page 

Acceptance of Terms

By using and visiting the JourneyŌM website and any linked pages, you agree to the following terms and conditions. If you do not agree with these terms, you are authorized to use the website.

No Warranty

All website material, linked pages, and content are provided “as is” without warranty of any kind. JourneyŌM disclaims any responsibility for the accuracy, content, or availability of information found on a site that links to or from the website (a “third party site”).

Responsibility of the User

It is the responsibility of the user to evaluate the accuracy, completeness, and usefulness of any information, opinion, advice, statement, and all other content on this website. JourneyŌM does not guarantee the accuracy or reliability of any information provided on this website.

Limitation of Liability

In no event will JourneyŌM, its domain maintainers, server administrators, affiliates, directors, officers, agents, employees, personnel, and contributors, or any other person or entity involved in creating, producing, or distributing information through the JourneyŌM website be liable for any direct, indirect, incidental, punitive, special, or consequential damages arising out of any use or inability to use the website and any linked pages.

Legal Compliance